The Latest Breaking News from Pfizer

Dr Aseem Malhotra believes booster was a factor in his father's death at 73 but other specialists insist vaccine saves lives on a huge scale

Central bank and banking regulator’s Guo Shuqing sends first signal that sector led by Alibaba, Tencent, Didi and Meituan may finally be off the hook

The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive

Social media users shared a range of false claims this week

Policymakers are now squarely focused on reviving the economy. But some analysts warned against ‘excessive optimism’ about when pre-pandemic growth rates will return

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…